White Pine Capital LLC Boosts Holdings in KORU Medical Systems, Inc. (NASDAQ:KRMD)

White Pine Capital LLC increased its holdings in KORU Medical Systems, Inc. (NASDAQ:KRMD) by 25.6% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 157,917 shares of the company’s stock after purchasing an additional 32,176 shares during the period. White Pine Capital LLC owned approximately 0.34% of KORU Medical Systems worth $608,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. XTX Topco Ltd purchased a new stake in KORU Medical Systems during the third quarter valued at about $34,000. Connor Clark & Lunn Investment Management Ltd. lifted its stake in shares of KORU Medical Systems by 77.7% in the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 61,412 shares of the company’s stock valued at $168,000 after acquiring an additional 26,860 shares during the last quarter. Geode Capital Management LLC boosted its holdings in KORU Medical Systems by 6.5% during the 3rd quarter. Geode Capital Management LLC now owns 462,128 shares of the company’s stock valued at $1,262,000 after acquiring an additional 28,323 shares during the period. Calamos Advisors LLC bought a new position in KORU Medical Systems during the 4th quarter worth approximately $250,000. Finally, Empire Financial Management Company LLC purchased a new position in KORU Medical Systems in the 3rd quarter worth approximately $259,000. Institutional investors own 58.60% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have recently weighed in on KRMD shares. Lake Street Capital increased their price objective on KORU Medical Systems from $4.00 to $5.00 and gave the company a “buy” rating in a research note on Tuesday, January 14th. Piper Sandler upped their price target on shares of KORU Medical Systems from $3.00 to $3.50 and gave the company an “overweight” rating in a report on Thursday, November 14th. Canaccord Genuity Group raised their price target on shares of KORU Medical Systems from $3.00 to $4.00 and gave the stock a “buy” rating in a report on Thursday, November 14th. Finally, Craig Hallum upped their price objective on shares of KORU Medical Systems from $5.00 to $6.00 and gave the company a “buy” rating in a research note on Friday, January 17th. Four investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, KORU Medical Systems presently has a consensus rating of “Buy” and an average price target of $4.50.

KORU Medical Systems Trading Up 2.2 %

Shares of KRMD stock opened at $4.75 on Friday. The stock has a fifty day moving average of $4.12 and a 200 day moving average of $3.21. KORU Medical Systems, Inc. has a 52 week low of $2.01 and a 52 week high of $5.05. The company has a quick ratio of 2.37, a current ratio of 2.99 and a debt-to-equity ratio of 0.01.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.